Hextar Healthcare Bhd (XKLS:7803) EBITDA Margin %: -8.68% (As of Mar. 2026)


What is Hextar Healthcare Bhd EBITDA Margin %?

Hextar Healthcare Bhd XKLS:7803 EBITDA Margin % is -8.68% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,585 Chemicals companies, Hextar Healthcare Bhd ranks worse than 93.75% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hextar Healthcare Bhd's EBITDA for the three months ended in Mar. 2026 was RM-2.7 Mil. Hextar Healthcare Bhd's Revenue for the three months ended in Mar. 2026 was RM31.0 Mil. Therefore, Hextar Healthcare Bhd's EBITDA margin for the quarter that ended in Mar. 2026 was -8.68%.


Hextar Healthcare Bhd  (XKLS:7803) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hextar Healthcare Bhd EBITDA Margin % Related Terms


Hextar Healthcare Bhd EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Hextar Healthcare Bhd's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hextar Healthcare Bhd EBITDA Margin % Chart

Hextar Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.08 -27.31 -34.49 -0.96 -13.65

Hextar Healthcare Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.70 -16.94 -14.91 -59.49 -8.68

XKLS:7803 vs LIN, SHW, ECL: EBITDA Margin % Comparison

For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hextar Healthcare Bhd EBITDA Margin % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hextar Healthcare Bhd's EBITDA Margin % falls into.



Hextar Healthcare Bhd EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hextar Healthcare Bhd's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.219/148.114
=-13.65 %

Hextar Healthcare Bhd's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.694/31.049
=-8.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -8.68% mean?
Hextar Healthcare Bhd (XKLS:7803) has a EBITDA Margin % of -8.68% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hextar Healthcare Bhd and its competitors. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1486 out of 1585 companies in the Chemicals industry, placing it in the top 93.8%.
Is Hextar Healthcare Bhd's EBITDA Margin % too high?
Hextar Healthcare Bhd's current EBITDA Margin % is -8.68%. Based on the distribution chart, Hextar Healthcare Bhd ranks #1486 out of 1585 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Hextar Healthcare Bhd's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1486 out of 1585 companies for EBITDA Margin %. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current EBITDA Margin % is -8.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.16, compared to a current price of RM0.06 — trading 62.5% below its estimated fair value. The current EBITDA Margin % is -8.68%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current EBITDA Margin % is -8.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hextar Healthcare Bhd Business Description

Address Jalan Bercham, Lot 138201, Off 3/4 Mile, Kawasan Perindustrian Bercham, Ipoh, PRK, MYS, 31400
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.